LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Athira Pharma (NASDAQ: ATHA)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ATHA Athira Pharma
San Martin Javier / officer: CHIEF MEDICAL OFFICER
01/02/2025
Sell
$0.56
10,826
$6K
35,841
NASDAQ ATHA Athira Pharma
Litton Mark James / director, officer: President and CEO
01/02/2025
Sell
$0.56
25,107
$14K
242,591
NASDAQ ATHA Athira Pharma
CHURCH KEVIN / officer: CHIEF SCIENTIFIC OFFICER
01/02/2025
Sell
$0.56
8,510
$5K
130,761
NASDAQ ATHA Athira Pharma
CHURCH KEVIN / officer: CHIEF SCIENTIFIC OFFICER
11/18/2024
Buy
$0.55
9,920
$5K
102,604
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
01/02/2025
Sell
$0.56
2,881
$2K
89,724
NASDAQ ATHA Athira Pharma
Renninger Robert / officer: VP of Finance
11/18/2024
Buy
$0.55
3,651
$2K
80,246
NASDAQ ATHA Athira Pharma
Worthington Mark / officer: General Counsel and CCO
01/02/2025
Sell
$0.56
8,510
$5K
83,735
NASDAQ ATHA Athira Pharma
Worthington Mark / officer: General Counsel and CCO
11/18/2024
Buy
$0.55
3,651
$2K
55,578